European Journal of Molecular & Clinical Medicine

As indicated by Ayurvedic pharmacology the medication activity is credited to specific standards in particular Rasa, Guna, Virya, Vipaka and Prabhava. It was found that drugs and the living body share a composition known as Panchabhutika, and that, when used responsibly, drugs have the potential to affect several aspects of the body. The enormous investments in research are pointless and fruitless if the Ayurvedic concepts are not correctly understood and translated in internationally accepted language. Therefore, it is crucial to reestablish Ayurvedic ideas in modern contexts by employing methods made possible by technological progress in the new millennium. Many of the Ayurvedic ideas contained in the Samhitas may appear simple at first glance, but their brief presentation makes them quite challenging to grasp. Certain ideas need to be investigated, according to how well they can be put into practice. This includes one such concept which is known as Prabhava. To understand these criteria, a methodical approach must be actively fostered. The purpose of this survey is to highlight the concept of Prabhava and its relevance in the modern era.

Ayurveda is seen as one of the ancient medical systems that predate even the
advent of modern science. This time-honored method of medicine has not been thoroughly
studied by modern science. The traditional medical experience opens new doors for herbal
research. The lack of knowledge of the similarities and distinctions between these systems'
inherent strengths and weaknesses are the primary obstacles to their integration. A
reviewer attempts to bring the concepts of Ayurveda to the fore that are centuries old and
puts them to the test in the modern context. This would serve the young physicians and
researchers and enable them to grasp conventional systems better, improve upon their
similar ideas, and promote universal acceptance of the same ideas in these systems.

Today, due to online working platform, everyone requires computer device and
used for long time. Resulting multi-factorial disease called Computer Vision Syndrome. In
modern lifestyle, every person is getting affected due to radiation may be due to VDT
(Video display terminals), computer, T.V. and CFL lamp, mobile etc. Symptoms known by
video display terminal users include many symptoms, thus term “Computer Vision
Syndrome”. In modern Science, lubricating medicine (eye drops) available but has not
specific effect for long time on CVS. Ayurveda deals with modification in the lifestyle
which is beneficial for the individual to remain healthy. Hence eye exercise, , Triphala
Kwath eye wash and Triphala Ghrita sytemically will be use for the treatment of CVS .
Objectives To study the efficacy of combine effect of Eye Exercise + Triphala Kwath Eye
Wash +Triphala Ghrita Systemically in the management of Computer Vision Syndrome.
Methodology- The study is Control Randomised clinical observational study. method -
100 patients of CVS will be treated by randomly dividing them into three, Group I having
40 patients will be subjected to Eye Exercise + Triphala Kwath Eye Wash +Triphala
Ghrita Systemically. Group II having 40 patient will be subjected to Eye Exercise +
Triphala Kwath Eye wash. Groups.III having 20 patient will be subjected to Exercise +
Instillation distilled (demineralised and sterilized) water patients will be treated. Results
The result will draw from the study of observation after treatment Conclusion The
Conclusion drawn from the observation and result.

Ayurveda has enough potential and possibilities to be employed both for prevention and treatment of COVID-19. This will provide an important opportunity for learning and generating credible evidence. It is pertinent to reiterate that participation of Ayurveda in addressing the COVID-19 challenge in India should not remain limited and seen as the extension of healthcare services and support to bio-medical system. Indeed, with adequate monitoring and data keeping during the implementation, important lessons and research directions are likely to emerge on the management of increasingly frequent and virulent communicable diseases. Implementation of proposed action is likely to provide evidence-based insights strengthening the scope of Ayurveda beyond preventive health care and care for non-communicable diseases. This Paper dealt with how Brand recognition of Ayurvedic food products during pandemic period.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an infectious pathogen rapidly spreading throughout the world. The disease has become a global pandemic having approximately thirty four million disease cases with one million reported deaths, worldwide. The immuno compromised and/or old age people are most susceptible to severe form of the disease. The pathogenic virus enters the human body causing numerous changes in the immune system regulation. Several studies report that coronavirus causes ‘cytokine storm’ leading to adverse effects of host immune response. Thus, it becomes necessary to prevent the pathogen from hijacking the host’s immune system. The present study elaborately describes the scope of immunomodulation in COVID-19 along with ayurvedic herbs as potential immunomodulating drugs to curtail the effects of the pathogenic virus. Briefly, the study provides dual strategy of immunomodulation and antiviral herbal compounds as a measure to control the pandemic at current stage.

Background: Nishamalaki or Nisha Amalaki representing various combination formulations of Turmeric and Indian gooseberry is recommended in Ayurveda, proven efficacious and widely practiced in the management and prevention of complications of Madhumeha (Diabetes).
Aims: To assess the effectiveness of scaling and root planing on the glycemic status and gingival crevicular fluid (GCF) levels of Malondialdehyde, Superoxide Dismutase, Catalase and Osteocalcin in Type II diabetes patients with chronic periodontitis under systemic administration of Nishamalaki, an ayurvedic hypoglycemic formulation.
Material and methods: The study included 90 newly diagnosed Type II diabetic patients in the age group between 30 to 50 years with mild to moderate chronic periodontitis and was randomly divided into 45 patients of two groups each. Group A were Type II diabetic patients with mild to moderate chronic periodontitis taking supplements of Nishamalaki 1 gram twice daily for 3 months and Group B were Type II diabetic patients with mild to moderate chronic periodontitis undergoing scaling and root planing and receiving supplements of Nishamalaki 1 gram twice daily for 3 months.
Results: Independent t-test has been applied to compare the two groups. It has been observed there is no significant difference exists between the two groups. However administration of Nishamalaki and scaling has been all effective in group B parameters.
Conclusion: Nishamalaki showed protective effect and appeared to be useful in reducing the glycemic status, levels of superoxide dismutase, catalase, lipid peroxidase and osteocalcin in GCF in type-2 diabetes patients with chronic periodontitis.